SG Americas Securities LLC Sells 7,520 Shares of Integer Holdings Co. (NYSE:ITGR)

SG Americas Securities LLC cut its holdings in shares of Integer Holdings Co. (NYSE:ITGRGet Rating) by 44.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,499 shares of the medical equipment provider’s stock after selling 7,520 shares during the period. SG Americas Securities LLC’s holdings in Integer were worth $591,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ITGR. Franklin Resources Inc. increased its position in shares of Integer by 38.9% during the second quarter. Franklin Resources Inc. now owns 2,722,621 shares of the medical equipment provider’s stock worth $192,381,000 after acquiring an additional 762,579 shares in the last quarter. Victory Capital Management Inc. grew its position in Integer by 95.5% in the 2nd quarter. Victory Capital Management Inc. now owns 867,575 shares of the medical equipment provider’s stock worth $61,303,000 after purchasing an additional 423,888 shares in the last quarter. Hodges Capital Management Inc. bought a new stake in Integer in the 2nd quarter worth about $4,317,000. Vanguard Group Inc. grew its position in Integer by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 3,635,569 shares of the medical equipment provider’s stock worth $292,918,000 after purchasing an additional 48,145 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new stake in Integer in the 1st quarter worth about $3,846,000. 98.42% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ITGR. StockNews.com began coverage on shares of Integer in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Benchmark reduced their price objective on shares of Integer to $90.00 in a research report on Tuesday, November 1st. Finally, KeyCorp reduced their price objective on shares of Integer from $97.00 to $84.00 and set an “overweight” rating for the company in a research report on Thursday, October 6th.

Integer Stock Up 1.3 %

Integer stock opened at $74.21 on Monday. Integer Holdings Co. has a twelve month low of $50.05 and a twelve month high of $88.58. The firm has a 50 day moving average price of $70.58 and a 200-day moving average price of $66.74. The company has a market capitalization of $2.46 billion, a P/E ratio of 34.52 and a beta of 1.17. The company has a quick ratio of 1.74, a current ratio of 2.80 and a debt-to-equity ratio of 0.68.

Integer (NYSE:ITGRGet Rating) last released its earnings results on Thursday, October 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.06. Integer had a net margin of 5.47% and a return on equity of 9.24%. The firm had revenue of $342.68 million during the quarter, compared to the consensus estimate of $343.15 million. As a group, equities analysts predict that Integer Holdings Co. will post 3.77 EPS for the current year.

Insider Activity at Integer

In other Integer news, CEO Joseph W. Dziedzic purchased 4,000 shares of the company’s stock in a transaction that occurred on Friday, December 16th. The shares were bought at an average cost of $61.95 per share, for a total transaction of $247,800.00. Following the purchase, the chief executive officer now owns 122,378 shares of the company’s stock, valued at approximately $7,581,317.10. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.01% of the stock is currently owned by corporate insiders.

Integer Profile

(Get Rating)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.

Recommended Stories

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGRGet Rating).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.